Search results for " report"

Article Fifteen Years of Progress: Biopharmaceutical Industry Survey Results
The annual report has expanded to include 60 questions with nearly 500 pages of analysis and data (1,2). Manufacturing capacity issues have always been at the core of the annual survey, but as the ind…

Article Changing the Culture of Cell Culture: Applying Best Practices and Authentication to Ensure Scientific Reproducibility
…ological reagents and reference materials, study design, laboratory protocols, and data analysis and reporting (3). Although each contributes to a systemic problem that requires extensive changes in …

Article Technologies and Practices Must Evolve to Meet Demand
The respondents reported that they were involved in many phases of drug development and manufacturing including process development, drug-substance and finished product manufacturing, quality control,…

Article Impact of Media Components on CQAs of Monoclonal Antibodies
Asparagine concentration has been reported to affect galactosylation level. Cysteine, along with temperature shift, is believed to reduce protein aggregates and increase their stability in culture …

Article Establishing Acceptance Criteria for Analytical Methods
Closing the Gap The % relative standard deviation (RSD)/% CV and % recovery should be report-only and should be included in any evaluation of an analytical method per ICH Q2 (3). Measurements that…

Article 2014 Manufacturing Trends and Outlook
Less than 3% reported a drop in production. Only 8.1% said their companies decreased spending for biopharmaceutical equipment and services in 2013 compared to 2012; 37.8% reported increased spending; …

Article Trends in Downstream Bioprocessing
And in BioPlan’s recently released 10th Annual Report and Survey of Biopharmaceutical Manufacturing (2), it is found that DSP is one of the top areas in which both industry suppliers and end-users are…

Article Downstream Processing Continues to Worry CMOs
…bottlenecks don’t appear to show any signs of abating, according to BioPlan Associates 13th Annual Report and Survey of Biopharmaceutical Manufacturing Capacity and Production (1). In fact, nearl…

Article Regulatory Challenges in the QbD Paradigm
With respect to product and process changes, the regulation states that each change in product, production process, quality controls, equipment, or facilities must be reported to the agency (16). This…

Article Biomanufacturing: Demand for Continuous Bioprocessing Increasing
This is up from 68% based on data from our 2016 Annual Report (1). According to BioPlan’s 17th Annual Report and Survey on Biopharmaceutical Manufacturing Capacity and Production (2), there has…

Previous PageNext Page